Physician profile
Ronna Wright
NPI 1609850106
$2,974.66
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,336 · 2020: $1,628 · 2021: $11.28.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $464.41 | 2019-2020 | |
| Novo Nordisk INC | $401.58 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $397.51 | 2019-2021 | |
| Amgen INC. | $283.88 | 2019-2020 | |
| Pfizer INC. | $246.05 | 2019-2020 | |
| Lilly USA, LLC | $180.81 | 2019-2020 | |
| Allergan, INC. | $151.86 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $128.10 | 2019-2020 | |
| Glaxosmithkline, LLC. | $99.28 | 2019-2020 | |
| Amarin Pharma, INC. | $84.64 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $74.77 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $74.01 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $70.65 | 2019 | |
| Sanofi-Aventis U.S. LLC | $56.08 | 2019-2020 | |
| Astellas Pharma US INC | $45.72 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $42.32 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $34.65 | 2020 | |
| Genentech USA, INC. | $31.68 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $30.71 | 2019 | |
| Abbvie INC. | $30.20 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $21.02 | 2020 | |
| Sanofi Pasteur INC. | $13.01 | 2019 | |
| Novartis Pharmaceuticals Corporation | $11.72 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronna Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.